Results 1 to 10 of about 99,547,245 (298)
A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulationNovel homozygous CTLA-4 variant in immune dysregulation [PDF]
Catak et al. describe the first case of homozygous CTLA-4 deficiency, which drives severe early-onset autoimmunity through profound T and B cell dysregulation.
Mehmet Cihangir Catak +17 more
doaj +5 more sources
Autosomal recessive human CTLA-4 deficiency with autoimmune infiltrationHuman CTLA-4 deficiency [PDF]
A report in this issue of JHI deepens our understanding of human disease associated with loss of CTLA-4.
Helen C. Su
doaj +2 more sources
64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues. [PDF]
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) targeted therapy by anti-CTLA-4 monoclonal antibody (mAb) is highly effective in cancer patients.
Kei Higashikawa +6 more
doaj +2 more sources
The role and function of CTLA-4 in Sjögren’s syndrome [PDF]
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is a key immune checkpoint involved in immune regulation. CTLA-4 inhibitors have been widely used in cancer therapy and have attracted increasing attention in autoimmune diseases such as Sjögren’s ...
Ji Wen +4 more
doaj +2 more sources
DNA-PKcs orchestrates CTLA-4 depletion-induced senescence in cancer cells [PDF]
Immune checkpoints such as cytotoxic T-lymphocyte–associated protein 4 (CTLA-4), programmed cell death 1 (PD-1), and programmed cell death ligand 1 (PD-L1) have been targeted in cancer therapy, however, the efficacy of these interventions remains limited.
Je-Jung Lee +7 more
doaj +2 more sources
Immune dysregulation from a novel CTLA-4 haploinsufficiency variantImmune dysregulation from a novel CTLA-4 haploinsufficiency variant [PDF]
We describe a novel CTLA-4 p.Tyr218* variant associated with immune dysregulation across four generations. The mutation truncates the cytoplasmic tail, reducing CTLA-4 stability and transendocytosis, consistent with haploinsufficiency and autoimmunity ...
Nina N. Brodsky +9 more
doaj +2 more sources
Background: Rheumatoid arthritis (RA) is related to several pivotal susceptibility genes, including cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and costimulatory molecule (CD80/CD86) genes. Although the connection between polymorphisms of CTLA-4
Weixi Liu +7 more
doaj +1 more source
Identification of CTLA-4-Positive Cells in the Human Tonsil
CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) was originally defined as a T-lymphocyte antigen and was used as a target in cancer immunotherapy. Unfortunately, the existence of CTLA-4 in cells other than T-lymphocytes is often overlooked. The goal
Markus Tiemann +3 more
doaj +1 more source
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is a critical inhibitory checkpoint molecule, and monoclonal antibodies (mAbs) targeting CTLA-4 that restore anti-tumor T cell immunity have achieved clinical success.
Jiawei Guan +16 more
doaj +1 more source
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a check point protein expressed on the surface of T cells and plays a central role in regulating the immune response.
Dong Wei +12 more
doaj +1 more source

